Matthew Scott Harris's Net Worth
$801 Thousand
Who is Matthew Scott Harris?
Matthew Scott Harris does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Altimmune, Inc..
SEC CIK
Matthew Scott Harris's CIK is 0001787762
Past Insider Trading and Trends
2023 was Matthew Scott Harris's most active year for acquiring shares with 7 total transactions. Matthew Scott Harris's most active month to acquire stocks was the month of December. 2024 was Matthew Scott Harris's most active year for disposing of shares, totalling 6 transactions. Matthew Scott Harris's most active month to dispose stocks was the month of January. 2022 saw Matthew Scott Harris paying a total of $77,368.36 for 161,742 shares, this is the most they've acquired in one year. In 2022 Matthew Scott Harris cashed out on 68,349 shares for a total of $243,020.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Altimmune, Inc. (ALT) Snapshot price: $10.42
Chief Medical OfficerMatthew Scott Harris owns 53,633 units of Common Stock, par value $0.0001 which is worth $558,855.86. From 2019 to 2024 Matthew Scott Harris acquired a total of 101,220 shares in Altimmune, Inc. at a cost of $172,645.17, Matthew also disposed a total of 47,587 shares of Altimmune, Inc. equalling to $414,963.26.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.38% | 9.81K |
$9.56 | -$39,528.12 | 53.63K |
Feb 1 - Feb 2
| |||
Form 4
| +28.89% | 9.82K |
$6.25 | -$17,786.87 | 43.83K |
Jan 30 - Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +2.07% | 691 |
$2.81 | $1,941.71 | 34K |
Jul 31
| |||
Form 4
| +42.90% | 10K |
$4.22 | $42,200.00 | 33.31K |
Mar 23
| |||
Form 4
| +30.23% | 5.41K |
$15.04 | -$35,554.56 | 23.31K |
Feb 2
| |||
Form 4
| +41.83% | 5.28K |
$12.00 | -$16,851.52 | 17.9K |
Jan 31 - Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
| +9.32% | 1.08K |
$6.86 | $7,381.36 | 12.62K |
Jul 31
| |||
Form 4
|
—
|
0
|
$4.72 | -$167,961.00 | 11.54K |
Scheduled
|
Feb 28
| ||
Form 4
| +100.36% | 5.78K |
$7.42 | -$5,072.34 | 11.54K |
Jan 31 - Feb 2
| |||
Form 4
| +14.39% | 725 |
$7.71 | $5,589.39 | 5.76K |
Jul 31
| |||
Form 4
| +23.79% | 968 |
$12.14 | $11,751.52 | 5.04K |
Jan 31 - Feb 1
| |||
Form 4
| -49.67% | -4.01K |
$10.02 | -$40,230.30 | 4.07K |
Scheduled
|
Nov 12
| ||
Form 4
|
∞
| 8.08K |
$1.46 | $11,802.64 | 8.08K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||